Pruritus: Unapproved treatments or indications

Clinics in Dermatology

Volumn 18, Issue 2, 2000, Pages 149-152

  Millikan, Larry E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIPRURITIC AGENT; ASTEMIZOLE; CALAMINE; CAMPHOR; CETIRIZINE; CROTAMITON; DOXEPIN; FEXOFENADINE; MENTHOL; PHENOBARBITAL; PHENOL; PRAMOCAINE; PREDNISONE; PSORALEN; SALICYLIC ACID METHYL ESTER; STEROID; TAR; TERFENADINE; ZINC OXIDE;

BALNEOTHERAPY; DRUG EFFICACY; DRUG INDICATION; HUMAN; PRIORITY JOURNAL; PRURITUS; SHORT SURVEY;

EID: 0034603474     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00104-2     Document Type: Review

References (6)

1. Millikan LE. Treating pruritus: What's new in safe relief of symptoms? Postgrad Med 1996;99:173-84.
2. Bernhard JD. Pruritus in skin diseases. In: Bernhard JD, editor. Itch: Mechanisms and management of pruritus. New York: McGraw-Hill, 1994:37-67.
3. Greaves, MW. Itching and urticaria (Summary of Talk, AAD '99). Dermtol Times 1999;20:5-6.
4. Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Arch Dermatol 1995;403:xx-xx.
5. Monroe EW. Chronic urticaria: Review of non-sedating H1 antihistamines in treatment. J Am Acad Dermatol 1998;19: 842-9.
6. Loratadine and fexofenadine. In: Physician's desk reference, 1999. Montvale, NJ: Medical Economics Publishing.